These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 31434703)

  • 1. Tissue factor pathway inhibitor primes monocytes for antiphospholipid antibody-induced thrombosis.
    Müller-Calleja N; Hollerbach A; Ritter S; Pedrosa DG; Strand D; Graf C; Reinhardt C; Strand S; Poncelet P; Griffin JH; Lackner KJ; Ruf W
    Blood; 2019 Oct; 134(14):1119-1131. PubMed ID: 31434703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies.
    Müller-Calleja N; Ritter S; Hollerbach A; Falter T; Lackner KJ; Ruf W
    Blood Adv; 2018 May; 2(9):979-986. PubMed ID: 29716893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibody-induced cellular responses depend on epitope specificity : implications for treatment of antiphospholipid syndrome.
    Müller-Calleja N; Hollerbach A; Häuser F; Canisius A; Orning C; Lackner KJ
    J Thromb Haemost; 2017 Dec; 15(12):2367-2376. PubMed ID: 29024318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein s.
    Reverter JC; Tàssies D; Font J; Monteagudo J; Escolar G; Ingelmo M; Ordinas A
    Arterioscler Thromb Vasc Biol; 1996 Nov; 16(11):1319-26. PubMed ID: 8911269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4.
    Laplante P; Fuentes R; Salem D; Subang R; Gillis MA; Hachem A; Farhat N; Qureshi ST; Fletcher CA; Roubey RA; Merhi Y; Thorin É; Levine JS; Mackman N; Rauch J
    Lupus; 2016 Feb; 25(2):162-76. PubMed ID: 26391610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the tissue factor coagulation initiation complex prevents antiphospholipid antibody development.
    Müller-Calleja N; Grunz K; Nguyen TS; Posma J; Pedrosa D; Meineck M; Hollerbach A; Braun J; Muth S; Schild H; Saar K; Hübner N; Krishnaswamy S; Royce J; Teyton L; Lemmermann N; Weinmann-Menke J; Lackner KJ; Ruf W
    Blood; 2024 Mar; 143(12):1167-1180. PubMed ID: 38142429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway.
    López-Pedrera C; Buendía P; Cuadrado MJ; Siendones E; Aguirre MA; Barbarroja N; Montiel-Duarte C; Torres A; Khamashta M; Velasco F
    Arthritis Rheum; 2006 Jan; 54(1):301-11. PubMed ID: 16385547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway.
    Yasuda S; Bohgaki M; Atsumi T; Koike T
    Immunobiology; 2005; 210(10):775-80. PubMed ID: 16325497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells.
    Pierangeli SS; Harris EN
    Lupus; 2003; 12(7):539-45. PubMed ID: 12892395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cofactor-independent human antiphospholipid antibodies induce venous thrombosis in mice.
    Manukyan D; Müller-Calleja N; Jäckel S; Luchmann K; Mönnikes R; Kiouptsi K; Reinhardt C; Jurk K; Walter U; Lackner KJ
    J Thromb Haemost; 2016 May; 14(5):1011-20. PubMed ID: 26786324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus.
    Adams MJ; Palatinus AA; Harvey AM; Khalafallah AA
    Lupus; 2011 Dec; 20(14):1474-83. PubMed ID: 21993387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.
    Redecha P; Franzke CW; Ruf W; Mackman N; Girardi G
    J Clin Invest; 2008 Oct; 118(10):3453-61. PubMed ID: 18802482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes.
    Basavaraj MG; Gruber FX; Sovershaev M; Appelbom HI; Osterud B; Petersen LC; Hansen JB
    Thromb Res; 2010 Nov; 126(5):418-25. PubMed ID: 20723970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracing the molecular pathogenesis of antiphospholipid syndrome.
    Weiler H
    J Clin Invest; 2008 Oct; 118(10):3276-8. PubMed ID: 18802489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: pathogenic mechanisms of the antiphospholipid syndrome.
    Du VX; Kelchtermans H; de Groot PG; de Laat B
    Thromb Res; 2013 Sep; 132(3):319-26. PubMed ID: 23958468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tissue factor in the maternal immunological attack of the embryo in the antiphospholipid syndrome.
    Girardi G
    Clin Rev Allergy Immunol; 2010 Dec; 39(3):160-5. PubMed ID: 19921475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tissue factor in thrombosis in antiphospholipid antibody syndrome.
    Boles J; Mackman N
    Lupus; 2010 Apr; 19(4):370-8. PubMed ID: 20353972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid-mediated thrombosis: interplay between anticardiolipin antibodies and vascular cells.
    López-Pedrera C; Buendía P; Barbarroja N; Siendones E; Velasco F; Cuadrado MJ
    Clin Appl Thromb Hemost; 2006 Jan; 12(1):41-5. PubMed ID: 16444433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome.
    Amengual O; Atsumi T; Khamashta MA; Hughes GR
    Thromb Haemost; 1998 Feb; 79(2):276-81. PubMed ID: 9493575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome.
    Cuadrado MJ; Buendía P; Velasco F; Aguirre MA; Barbarroja N; Torres LA; Khamashta M; López-Pedrera C
    J Thromb Haemost; 2006 Nov; 4(11):2461-9. PubMed ID: 16968331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.